FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038401270> ?p ?o ?g. }

• W2038401270 endingPage "238" @default.
• W2038401270 startingPage "231" @default.
• W2038401270 abstract "A series of experiments was conducted to study cyclosporin A (CsA) pharmacokinetics in dogs and the factors influencing variability of blood concentrations. In a first study, influence of feeding on drug absorption and blood profile was evaluated. Administration of CsA as micro-emulsion (ME) formulation with food decreased the bioavailability by 22% and increased the individual variability of drug absorption. In a second study, pharmacokinetic profiles from laboratory fasted beagle dogs receiving orally CsA ME formulation were analyzed. CsA was measured in blood samples by high-performance liquid chromatography (HPLC, 34 profiles) and fluorescent polarization immunoassay (FPIA, 16 profiles). A two-compartment model with first-order absorption was used to calculate the pharmacokinetic parameters. Using FPIA, blood concentrations were 1.5 to 1.7 times higher than when using HPLC, but elimination half-life and MRT were similar. The coefficient of variation of key pharmacokinetic parameters ranged from 27 to 34% following HPLC assay. The same range of variation was obtained after FPIA assay. In a third study, in a clinical trial evaluating CsA for the treatment of canine atopic dermatitis, a single blood sample was collected in dogs which had received CsA for 28 days. No significant correlation was found between clinical improvement and CsA blood concentrations. Considering the large margin of safety of CsA in dogs, the limited inter-individual variability and the lack of correlation between blood concentrations and clinical response, routine monitoring of blood CsA does not appear necessary in dogs with atopic dermatitis." @default.
• W2038401270 created "2016-06-24" @default.
• W2038401270 creator A5010006386 @default.
• W2038401270 creator A5030990256 @default.
• W2038401270 creator A5067620076 @default.
• W2038401270 creator A5069824266 @default.
• W2038401270 date "2004-08-01" @default.
• W2038401270 modified "2023-09-25" @default.
• W2038401270 title "Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs" @default.
• W2038401270 cites W1512909729 @default.
• W2038401270 cites W1979881616 @default.
• W2038401270 cites W1983884060 @default.
• W2038401270 cites W1998550404 @default.
• W2038401270 cites W1998758469 @default.
• W2038401270 cites W2017102674 @default.
• W2038401270 cites W2017724335 @default.
• W2038401270 cites W2019276276 @default.
• W2038401270 cites W2019418296 @default.
• W2038401270 cites W2022275907 @default.
• W2038401270 cites W2031561954 @default.
• W2038401270 cites W2040838538 @default.
• W2038401270 cites W2041767673 @default.
• W2038401270 cites W2043782194 @default.
• W2038401270 cites W2044148793 @default.
• W2038401270 cites W2049170691 @default.
• W2038401270 cites W2052782411 @default.
• W2038401270 cites W2055595145 @default.
• W2038401270 cites W2061953334 @default.
• W2038401270 cites W2066684817 @default.
• W2038401270 cites W2068127163 @default.
• W2038401270 cites W2072857897 @default.
• W2038401270 cites W2081559924 @default.
• W2038401270 cites W2089369719 @default.
• W2038401270 cites W2091216349 @default.
• W2038401270 cites W2110011659 @default.
• W2038401270 cites W2117443974 @default.
• W2038401270 cites W2150307728 @default.
• W2038401270 cites W2160617213 @default.
• W2038401270 cites W2169850270 @default.
• W2038401270 cites W2335493818 @default.
• W2038401270 cites W2502670554 @default.
• W2038401270 cites W4230016581 @default.
• W2038401270 cites W4238637783 @default.
• W2038401270 cites W4244680959 @default.
• W2038401270 doi "https://doi.org/10.1111/j.1365-2885.2004.00587.x" @default.
• W2038401270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15305852" @default.
• W2038401270 hasPublicationYear "2004" @default.
• W2038401270 type Work @default.
• W2038401270 sameAs 2038401270 @default.
• W2038401270 citedByCount "59" @default.
• W2038401270 countsByYear W20384012702012 @default.
• W2038401270 countsByYear W20384012702013 @default.
• W2038401270 countsByYear W20384012702014 @default.
• W2038401270 countsByYear W20384012702015 @default.
• W2038401270 countsByYear W20384012702016 @default.
• W2038401270 countsByYear W20384012702017 @default.
• W2038401270 countsByYear W20384012702018 @default.
• W2038401270 countsByYear W20384012702019 @default.
• W2038401270 countsByYear W20384012702020 @default.
• W2038401270 countsByYear W20384012702022 @default.
• W2038401270 countsByYear W20384012702023 @default.
• W2038401270 crossrefType "journal-article" @default.
• W2038401270 hasAuthorship W2038401270A5010006386 @default.
• W2038401270 hasAuthorship W2038401270A5030990256 @default.
• W2038401270 hasAuthorship W2038401270A5067620076 @default.
• W2038401270 hasAuthorship W2038401270A5069824266 @default.
• W2038401270 hasConcept C112705442 @default.
• W2038401270 hasConcept C126322002 @default.
• W2038401270 hasConcept C1621761 @default.
• W2038401270 hasConcept C179998833 @default.
• W2038401270 hasConcept C181389837 @default.
• W2038401270 hasConcept C185592680 @default.
• W2038401270 hasConcept C203014093 @default.
• W2038401270 hasConcept C2776820430 @default.
• W2038401270 hasConcept C2778060338 @default.
• W2038401270 hasConcept C2778329239 @default.
• W2038401270 hasConcept C43617362 @default.
• W2038401270 hasConcept C71924100 @default.
• W2038401270 hasConcept C89838059 @default.
• W2038401270 hasConcept C98274493 @default.
• W2038401270 hasConceptScore W2038401270C112705442 @default.
• W2038401270 hasConceptScore W2038401270C126322002 @default.
• W2038401270 hasConceptScore W2038401270C1621761 @default.
• W2038401270 hasConceptScore W2038401270C179998833 @default.
• W2038401270 hasConceptScore W2038401270C181389837 @default.
• W2038401270 hasConceptScore W2038401270C185592680 @default.
• W2038401270 hasConceptScore W2038401270C203014093 @default.
• W2038401270 hasConceptScore W2038401270C2776820430 @default.
• W2038401270 hasConceptScore W2038401270C2778060338 @default.
• W2038401270 hasConceptScore W2038401270C2778329239 @default.
• W2038401270 hasConceptScore W2038401270C43617362 @default.
• W2038401270 hasConceptScore W2038401270C71924100 @default.
• W2038401270 hasConceptScore W2038401270C89838059 @default.
• W2038401270 hasConceptScore W2038401270C98274493 @default.
• W2038401270 hasIssue "4" @default.
• W2038401270 hasLocation W20384012701 @default.
• W2038401270 hasLocation W20384012702 @default.
• W2038401270 hasOpenAccess W2038401270 @default.

• next